News and Media
Latest news
Accord Healthcare nominated for 'Pf 2024' award
Read MoreWorld Cancer Day 2024: Accord committed to helping close the gap in cancer care
Read MoreAccord wins four ‘Pharmaceutical Technology Excellence’ awards
Read MoreAccord in 2023: Watch our End of Year video
Read MoreAccord Healthcare wins ‘CSR World Leader 2023’ award
Read MoreAccord Healthcare launches Accord Animal Health
Read MoreAccord Supporting World Menopause Day 2023
Read MoreSupporting IHP
Read MoreEuropean-wide legal guidance on medicines procurement
Read MorePressures on the pharmaceutical industry with The Generics Bulletin
Read MoreAccord Healthcare – The Guardian Future of Healthcare - Q1 2023
Read MoreAccord Womens Network
Read MoreAccord Healthcare marks World Cancer Day 2023
Read MoreAccord's approach to reducing environmental impact
Read MoreAccord and IHP at Christmas
Read MoreWe are delighted to be named winners at the Global Generics & Biosimilars 2022 Awards in Frankfurt.
Read MoreThank you to everyone who attended CPHI2022
Read MoreGrad Week 2022
Read MoreThe Times - Future of Pharma Supplement
Read MoreGGb Finalist
Read MoreInnovations in Oncology
Read MoreDepartment of International Trade and Health and Invest Newcastle Visit Accord’s Fawdon Site
Read MoreAccord Healthcare featured in The Guardian
Read MoreScience Jobs
Read MoreIHP Visit Fawdon
Read MoreSupporting IHP to Make it Better for those in Ukraine and beyond
Read MoreAccord Germany Turns 10
Read MoreAsk Accord - Peter Kelly
Read MoreBREAKING NEWS – New Partnership for Oncology Franchise
Read MoreEmployee Spotlight
Read MoreAccord Linkedin
Accord was delighted to host the Chancellor of the Exchequer, Rachel Reeves and Department of Science, Innovation and Technology’s Secretary of State, Peter Kyle today at our plant in Fawdon, Newcastle. They met with our colleagues and President EMENA, Paul Tredwell, learning about some of the work that goes into the production of essential medicines.
Their visit coincided with the launch of the new Life Sciences Innovative Manufacturing Fund (LSIMF) and the unlocking of a joint £50 million investment deal to boost the manufacture and production of Accord’s essential medicines in Fawdon. Accord is one of the UK’s largest providers of medicines to patients and is proud to supply around 10% of the volume of all medicines to the NHS.
We look forward to supporting the government as ever in their efforts to boost the supply of affordable, high-quality medicines in the UK.
